Study for Identifying Optimal Simvastatin Formulation for Uniform Time to Maximum Plasma Concentration
Status:
Terminated
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The inter- and intra-variability in the pharmacokinetic parameters of different formulations
and doses of simvastatin in healthy subjects and in subjects with celiac disease in remission
will be evaluated. Additionally, baseline values of pharmacokinetic parameters of simvastatin
for both study groups will be determined.